Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the potential intended...
Regenecell outlines assessment priorities for U.S. patients exploring stem cell therapy in Mexico